Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Concepedia

Concepedia

Publication | Closed Access

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

293

Citations

29

References

2021

Year

Shengxiang Ren, Jianhua Chen, Xingxiang Xu, Tao Jiang, Ying Cheng, Gongyan Chen, Yueyin Pan, Yong Fang, Qiming Wang, Yunchao Huang,

Journal of Thoracic Oncology

Camrelizumab Plus CarboplatinMedicineAdvanced Squamous NsclcPharmacologyClinical TrialsImmune Checkpoint InhibitorPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyPhase 3

References

	Year	Citations

Page 1

Page 1